1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Clinical Trial
Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of Pipeline,
By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Country
5.8. Clinical Trials Heat
Map
6.
Global Antimalarial Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value & Volume
6.2.
Market Share & Forecast
6.2.1. By Drug Type
(Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine,
Pyrimethamine, Others)
6.2.2. By Drug Class (Aryl
Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds,
Antimicrobials)
6.2.3. By Route of
Administration (Oral, Powder Inhalation, Intravenous Administration)
6.2.4. By Malaria Type
(Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium
Ovale, Plasmodium Knowlesi)
6.2.5. By Application
(Prevention, Treatment of Malaria)
6.2.6. By Distribution
Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)
6.2.7. By Company (2022)
6.2.8. By
Region
6.3. Product
Market Map
7.
Asia-Pacific Antimalarial Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value & Volume
7.2.
Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Drug Class
7.2.3. By Route of
Administration
7.2.4. By Malaria Type
7.2.5. By Application
7.2.6. By Distribution
Channel
7.2.7.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Antimalarial Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value & Volume
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Drug Class
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Malaria Type
7.3.1.2.5.
By Application
7.3.1.2.6.
By Distribution Channel
7.3.2.
India Antimalarial Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value & Volume
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Type
7.3.2.2.2.
By Drug Class
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Malaria Type
7.3.2.2.5.
By Application
7.3.2.2.6.
By Distribution Channel
7.3.3.
Japan Antimalarial Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value & Volume
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Type
7.3.3.2.2.
By Drug Class
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Malaria Type
7.3.3.2.5.
By Application
7.3.3.2.6.
By Distribution Channel
7.3.4.
South Korea Antimalarial Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value & Volume
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Type
7.3.4.2.2.
By Drug Class
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Malaria Type
7.3.4.2.5.
By Application
7.3.4.2.6.
By Distribution Channel
7.3.5.
Singapore Antimalarial Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value & Volume
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Type
7.3.5.2.2.
By Drug Class
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Malaria Type
7.3.5.2.5.
By Application
7.3.5.2.6.
By Distribution Channel
7.3.6.
Australia Antimalarial Drugs Market Outlook
7.3.6.1.
Market Size & Forecast
7.3.6.1.1.
By Value & Volume
7.3.6.2.
Market Share & Forecast
7.3.6.2.1.
By Drug Type
7.3.6.2.2.
By Drug Class
7.3.6.2.3.
By Route of Administration
7.3.6.2.4.
By Malaria Type
7.3.6.2.5.
By Application
7.3.6.2.6.
By Distribution Channel
8.
Europe Antimalarial Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value & Volume
8.2.
Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Drug Class
8.2.3. By Route of
Administration
8.2.4. By Malaria Type
8.2.5. By Application
8.2.6. By Distribution
Channel
8.2.7.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Antimalarial Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value & Volume
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Type
8.3.1.2.2.
By Drug Class
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Malaria Type
8.3.1.2.5.
By Application
8.3.1.2.6.
By Distribution Channel
8.3.2.
Germany Antimalarial Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value & Volume
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Type
8.3.2.2.2.
By Drug Class
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Malaria Type
8.3.2.2.5.
By Application
8.3.2.2.6.
By Distribution Channel
8.3.3.
United Kingdom Antimalarial Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value & Volume
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Type
8.3.3.2.2.
By Drug Class
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Malaria Type
8.3.3.2.5.
By Application
8.3.3.2.6.
By Distribution Channel
8.3.4.
Italy Antimalarial Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value & Volume
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Drug Type
8.3.4.2.2.
By Drug Class
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Malaria Type
8.3.4.2.5.
By Application
8.3.4.2.6.
By Distribution Channel
8.3.5.
Spain Antimalarial Drugs Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value & Volume
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Drug Type
8.3.5.2.2.
By Drug Class
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Malaria Type
8.3.5.2.5.
By Application
8.3.5.2.6.
By Distribution Channel
9.
North America Antimalarial Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value & Volume
9.2.
Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Drug Class
9.2.3. By Route of
Administration
9.2.4. By Malaria Type
9.2.5. By Application
9.2.6. By Distribution
Channel
9.2.7.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Antimalarial Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value & Volume
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Type
9.3.1.2.2.
By Drug Class
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Malaria Type
9.3.1.2.5.
By Application
9.3.1.2.6.
By Distribution Channel
9.3.2.
Mexico Antimalarial Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value & Volume
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Type
9.3.2.2.2.
By Drug Class
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Malaria Type
9.3.2.2.5.
By Application
9.3.2.2.6.
By Distribution Channel
9.3.3.
Canada Antimalarial Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value & Volume
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Type
9.3.3.2.2.
By Drug Class
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Malaria Type
9.3.3.2.5.
By Application
9.3.3.2.6.
By Distribution Channel
10.
South America Antimalarial Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value & Volume
10.2.
Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Drug Class
10.2.3. By Route of
Administration
10.2.4. By Malaria Type
10.2.5. By Application
10.2.6. By Distribution
Channel
10.2.7.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Antimalarial Drugs Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value & Volume
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Drug Type
10.3.1.2.2.
By Drug Class
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Malaria Type
10.3.1.2.5.
By Application
10.3.1.2.6.
By Distribution Channel
10.3.2.
Argentina Antimalarial Drugs Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value & Volume
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Drug Type
10.3.2.2.2.
By Drug Class
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Malaria Type
10.3.2.2.5.
By Application
10.3.2.2.6.
By Distribution Channel
10.3.3.
Colombia Antimalarial Drugs Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value & Volume
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Drug Type
10.3.3.2.2.
By Drug Class
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Malaria Type
10.3.3.2.5.
By Application
10.3.3.2.6.
By Distribution Channel
11.
Middle East and Africa Antimalarial Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value & Volume
11.2.
Market Share & Forecast
11.2.1. By Drug Type
11.2.2. By Drug Class
11.2.3. By Route of
Administration
11.2.4. By Malaria Type
11.2.5. By Application
11.2.6. By Distribution
Channel
11.2.7.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Antimalarial Drugs Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value & Volume
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Drug Type
11.3.1.2.2.
By Drug Class
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By Malaria Type
11.3.1.2.5.
By Application
11.3.1.2.6.
By Distribution Channel
11.3.2.
Saudi Arabia Antimalarial Drugs Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value & Volume
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Drug Type
11.3.2.2.2.
By Drug Class
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By Malaria Type
11.3.2.2.5.
By Application
11.3.2.2.6.
By Distribution Channel
11.3.3.
UAE Antimalarial Drugs Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value & Volume
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Drug Type
11.3.3.2.2.
By Drug Class
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By Malaria Type
11.3.3.2.5.
By Application
11.3.3.2.6.
By Distribution Channel
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1.
Cipla Ltd
14.2.2.
GlaxoSmithKline Plc
14.2.3.
Ipca Laboratories
Ltd.
14.2.4.
Merck & Co., Inc
14.2.5.
Novartis AG
14.2.6.
Zydus Cadila
14.2.7.
Sun Pharmaceutical
Industries Ltd. (Ranbaxy Laboratories)
14.2.8.
Strides Pharma
Science Limited
14.2.9.
Glenmark
Pharmaceuticals Ltd.
14.2.10.
Lincoln Pharmaceuticals
Ltd.
15. Strategic Recommendations